Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized placebo-controlled trial of clarithromycin for the management of sepsis
2006-004886-33Phase 3Active
- Sponsor
- National and Kapodistrian University of Athens School of Medicine
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sepsis, Bacteremia, acute pyelonephritis and 1 more comparing Clarithromycin arm with Placebo arm (2 arms). Primary endpoint: Mortality rate over follow-up. Started Jan 2007; status: active.
02
Drugs
clarithromycin
03
Conditions
sepsisBacteremiaacute pyelonephritisIntra-abdominal infection (IAI)
Beyond the preview
Go deeper on 2006-004886-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004886-33.